Evidence map›Paper›PMID 38772428›Full record

ArticleBrain, behavior, and immunity2024

Adipokines measured during pregnancy and at birth are associated with infant negative affect.

Elinor L Sullivan, Kelly R Molloy, Geoffrey A Dunn, Adriana L Balanzar, Anna S Young, Jennifer M Loftis, Jennifer C Ablow, Joel T Nigg, Hanna C Gustafsson

Abstract read
In one paragraph

Article in Brain, behavior, and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Gestational kynurenine metabolites mediate effects of pregnancy adiposity on child negative affect.Journal of child psychology and psychiatry, and allied disciplines · 2026
    Article
  3. Review
  4. The Evolving ADHD Phenotype in the Externalizing Context.The American journal of psychiatry · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elinor L SullivanDepartment of Psychiatry, Oregon Health & Science University, United States; Center for Mental Health Innovation, Oregon Health & Science University, United States; Division of Neuroscience, Oregon National Primary Research Center, United States. Electronic address: sullivel@ohsu.edu.
Kelly R MolloyDepartment of Psychiatry, Oregon Health & Science University, United States; Center for Mental Health Innovation, Oregon Health & Science University, United States.
Geoffrey A DunnDepartment of Psychiatry, Oregon Health & Science University, United States; Center for Mental Health Innovation, Oregon Health & Science University, United States.
Adriana L BalanzarDepartment of Psychiatry, Oregon Health & Science University, United States; Center for Mental Health Innovation, Oregon Health & Science University, United States.
Anna S YoungDepartment of Psychiatry, Oregon Health & Science University, United States; Center for Mental Health Innovation, Oregon Health & Science University, United States.
Jennifer M LoftisDepartment of Psychiatry, Oregon Health & Science University, United States; VA Portland Health Care System, United States.
Jennifer C AblowDepartment of Psychology, University of Oregon, United States.
Joel T NiggDepartment of Psychiatry, Oregon Health & Science University, United States; Center for Mental Health Innovation, Oregon Health & Science University, United States.
Hanna C GustafssonDepartment of Psychiatry, Oregon Health & Science University, United States; Center for Mental Health Innovation, Oregon Health & Science University, United States.

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
ADHD heterogeneity, mechanisms, and risk profileR37MH059105 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIGG, JOEL T · 2014 to 2023
$7.0M
Developmental origins and early detection of ADHD and dysregulatory psychopathologyR01MH124824 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI SULLIVAN, ELINOR L. · 2021 to 2025
$3.8M
The Impact of Maternal Obesity and Poor Antenatal Nutrition on Offspring RDoC Dimensions and Risk for Neurodevelopmental DisordersR01MH117177 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIGG, JOEL T, SULLIVAN, ELINOR L. · 2018 to 2022
$3.6M
Supplement to Prenatal and Early Life Predictors of Child PsychopathologyK01MH120507 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI GUSTAFSSON, HANNA C · 2019 to 2024
$934k
CSRD VA I01 CX002668NCATS NIH HHS UL1 TR002369NIH HHS P51 OD011092NIMH NIH HHS K01 MH120507NIMH NIH HHS R01 MH117177NIMH NIH HHS R01 MH124824NIMH NIH HHS R37 MH059105
6 · The paper itself

Abstract

backgroundIncreased adiposity during pregnancy may be related to offspring risk for mental health disorders, although the biological mechanisms are poorly understood. One promising hypothesis is that factors secreted from adipocytes such as leptin and adiponectin may explain this association. The current study examined whether pregnancy or umbilical cord blood concentrations of leptin and/or adiponectin a) predict elevated infant negative affect at 6 months (an early life marker of risk for psychopathology); and b) help explain the association between pregnancy adiposity and increased infant negative affect.

methodsData came from a prospective cohort (N = 305) of pregnant individuals and their offspring. Second trimester adiposity was assessed using air displacement plethysmography. Concentrations of leptin and adiponectin were measured in second trimester plasma and umbilical cord plasma. Infant negative affect was assessed by standardized observation at 6 months. Second trimester inflammation was assessed using a comprehensive panel of cytokines.

resultsLower second trimester adiponectin was associated with elevated infant negative affect, and mediated the effect of pregnancy adiposity on infant negative affect. This association was independent of the effect of second trimester inflammation. Umbilical cord leptin also predicted higher infant negative affect and mediated the association between pregnancy adiposity and infant negative affect.

conclusionsThis is the first study to link pregnancy adiponectin or cord blood leptin to infant markers of risk for psychopathology, and the first to demonstrate that these adipokines mediate the association between pregnancy adiposity and offspring behavioral outcomes, suggesting novel markers of risk and potential mechanisms of effect.

Indexed as

AdipokinesAdiponectinAdiposityAffectFetal BloodLeptinPregnancy Trimester, SecondAdultBiomarkersFemaleHumansInfantInfant, NewbornInflammationMalePregnancyAdipokinesAdiponectinBiomarkersLeptinAdipokineAdiponectinAdiposityInfant negative affectLeptinPregnancy

Identifiers

PMID38772428
PMCPMC11401062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.